2008 Workshop report – Regulation and reimbursement
Regulation and reimbursement - Two sides of the same coin? 16-17th January 2008, Surrey, UK Background The topic for this Workshop, held in Surrey, UK, January 2008, was a [...]
2007 Workshop report – Emerging markets: Models of best practice for regulatory review
Emerging markets: Models of best practice for the regulatory review of new medicines 5-6th December 2007, Geneva, Switzerland The CMR International Institute for Regulatory Science returned to Geneva for [...]
2007 Workshop report – New approaches to product approval
New approaches to product approval - Balancing early release with improved safety monitoring 14-15th June 2007, Sofitel Hotel, Washington DC, USA Different approaches have been adopted worldwide to make [...]
2007 Workshop report – Rethinking early clinical testing
Rethinking early clinical testing: The translation from laboratory to clinic 16-17th April 2007, Surrey, UK In March 2006, just over a year before this CMR International Institute Workshop took [...]
2006 Workshop report – Quality decision making
Quality decision making: Procedures and practices in drug development and the regulatory review 7-8th December 2006, Surrey, UK Benefit and risk for patients, the success or failure of companies’ [...]
2006 Workshop report – Asia’s role in global drug development
Global drug development: Asia's role and contribution 11-12th October 2006, Tokyo, Japan The pharmaceutical market in the Asia‑Pacific region (excluding Japan) currently accounts for less than 20% of the [...]
2006 Workshop report – New technologies and biomarkers
New technologies and biomarkers: The way ahead 11-12th May 2006, Washington DC, USA Overview Once again, the CMR International Institute for Regulatory Science assembled an impressive team of regulatory, [...]
2006 Workshop report – Emerging markets regulatory issues and impact on access
Emerging markets: Regulatory issues and the impact on patients' access to medicines 2nd-3rd March 2006, Geneva, Switzerland Introduction Convened in Geneva, close to the headquarters of the World Health [...]
2005 Workshop report – Structured approach to benefit risk decision making
Benefit-risk assessment model for medicines - Developing a structured approach to decision making 13-14th June 2005, The Georgetown Inn, Washington DC, USA As public accountability grows for decisions taken [...]
2005 Workshop report – A new paradigm for clinical research
A new paradigm for clinical research 3rd-4th October 2005, Mandarin Oriental Hotel, Washington DC, USA Current paradox The pharmaceutical industry’s investment in R&D is rising inexorably but success rates [...]